A Study to Evaluate the Efficacy and Safety of Tanfanercept (HL036) in Dry Eye Disease

NCT06400589 · clinicaltrials.gov ↗

PHASE3

Phase

SUSPENDED

Status

750

Enrollment

INDUSTRY

Sponsor class

Stopped Logistical issue

Conditions

Dry Eye

Interventions

DRUG: tanfanercept
DRUG: Vehicle

Sponsor

HanAll BioPharma Co., Ltd.